Ocean Nutrition Canada

DSM: A “confluence of completely unrelated events” has affected its 2013 results

DSM profits rise in 2013 despite sluggish nutrition performance

By Shane STARLING

Multiple issues in the omega-3 sector, a ‘saturated’ US food supplements market, a widespread consumer move to private label plus a strengthening euro have all impacted Dutch-Swiss ingredient giant DSM’s nutrition division in 2013, but it still delivered...

Q3 wrap: Nutrition stars for DSM and Naturex

Q3 wrap: Nutrition stars for DSM and Naturex

By Shane Starling

Royal DSM saw Q3 sales slip 7% to €2.3bn across all divisions with polymer intermediates performing worst, but as has been the case in recent quarters, the Dutch firm’s nutrition cluster held firm with 1% organic growth in difficult economic times.

ONC is strong in omega-3 supplements, but could drug apps hold greater promise?

DSM eyes generic omega-3 drug space with €420m ONC buy

By Shane Starling

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers